UBS AM
BHVN icon

UBS AM’s Biohaven BHVN Stock Holding History

UBS AM’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Sell
748
-617,432
-100% -$6.65M ﹤0.01% 3247
2026
Q1 		$5.23M Buy
618,180
+43,702
+8% +$478K ﹤0.01% 1541
2025
Q4 		$6.49M Buy
574,478
+2,567
+0.4% +$31.8K ﹤0.01% 1328
2025
Q3 		$8.58M Sell
571,911
-131,398
-19% -$1.91M ﹤0.01% 1126
2025
Q2 		$9.92M Buy
703,309
+113,694
+19% +$2.03M ﹤0.01% 1359
2025
Q1 		$14.2M Buy
589,615
+41,040
+7% +$1.45M ﹤0.01% 1097
2024
Q4 		$20.5M Buy
548,575
+39,953
+8% +$1.86M ﹤0.01% 936
2024
Q3 		$25.4M Buy
508,622
+431,954
+563% +$16.8M 0.01% 860
2024
Q2 		$2.66M Sell
76,668
-363,838
-83% -$14.4M ﹤0.01% 1841
2024
Q1 		$24.1M Buy
440,506
+1,300
+0.3% +$64.4K 0.01% 744
2023
Q4 		$18.8M Buy
439,206
+44,822
+11% +$1.39M 0.01% 783
2023
Q3 		$10.3M Buy
394,384
+86,308
+28% +$1.79M ﹤0.01% 945
2023
Q2 		$4.21M Hold
308,076
– – ﹤0.01% 1317
2023
Q1 		$4.21M Buy
+308,076
New +$4.9M ﹤0.01% 1317

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM's BHVN Position: Q2 2026 in Review

UBS AM reduced its Biohaven (BHVN) stake by 100% in Q2 2026, selling an estimated $6.65M and leaving 748 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3247.

UBS AM first reported a position in BHVN in Q1 2023 and has held it in 14 quarters since. The position peaked at $25.4M in Q3 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • UBS AM held 748 shares of Biohaven worth $11.1K as of Q2 2026.
  • UBS AM sold 617,432 Biohaven shares in Q2 2026, an estimated $6.65M.
  • Biohaven made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3247 holding.
  • UBS AM first reported a position in Biohaven in Q1 2023 and has held it in 14 quarters since.
  • UBS AM's Biohaven position peaked at $25.4M in Q3 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.